PAT 20A/B Study Guide - Final Guide: Insulin Glargine, Regular Insulin, Novo Nordisk
3 May 2016
School
Department
Course
Professor
Document Summary
Lowers blood glucose levels by stimulating peripheral glucose uptake by binding to insulin receptors on skeletal muscle and fat cells. Inhibits lipolysis ( breakdown of fat) and proteolysis (break down of proteins) Given in an emergency b/c it acts rapidly. Aspart & glulisine can be given intravenously. Used to control post-prandial( after meals) hyperglycemia. Used in the management of dka ** Used for intravenous treatment: onset 10-30 mins, duration--30-60 mins. Short-acting insulin is frequently combined with intermediate-acting insulin for physiologic regulation. Different from other immediate or long acting insulins. Glargine can be used to provide a basal level of insulin to pts. on an intensive insulin treatment program. Only given subcuatenously: not iv or im. Used for day to day control for pts with diabetes. Only subcutaneous: cannot be administered iv or im. Can decrease glucose & potassium levels: hypoglycemia.
